ACTIVE

PHARMA MANUFACTURING

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result6,2 k €+164,6 %over 1 year

Revenue3 M €+8,5 %over 1 year

Equity2,8 M €+0,4 %over 1 year

Workforce11,3 ETP+17,7 %over 1 year

Identity

Source · BCE/KBO

PHARMA MANUFACTURING is a Public limited company incorporated in 2001. Its main activity is: Manufacture of homogenised food preparations and dietetic food. Its registered office is in Gembloux. It employs on average 11,3 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0475.313.955
Incorporation: 16/07/2001
Legal form: Public limited company
Registered office: Rue Guillaume Fouquet,Isnes 16
5032 Gembloux · WallonieSee on map
Contributed capital: 62 000,00 €
Latest accounts: 31/12/2025
Average workforce: 11,3 ETP

Activities (NACE)

10860Manufacture of homogenised food preparations and dietetic food· main 10860Manufacture of homogenised food preparations and dietetic food 15880Manufacture of leather and related products 74820Other professional, scientific and technical activities 82920Packaging activities 82920Packaging activities+3

Joint committees (5)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 20 filings

Trend over 20 financial years

	2025		2024		2023		2022		2021
Income statement
Revenue	3 M €	+8.5%	2,8 M €	-4.4%	2,9 M €	-0.2%	2,9 M €	+2.8%	2,8 M €
EBITDA	173,8 k €	-3.0%	179,1 k €	-25.4%	240,3 k €	-54.5%	527,7 k €	+1846%	-30,2 k €
Operating result	-9,8 k €	-244%	6,8 k €	-68.2%	21,3 k €	-94.5%	390,7 k €	+341%	-162 k €
Net result	6,2 k €	+165%	2,4 k €	-83.5%	14,3 k €	-95.8%	338,1 k €	+308%	-162,9 k €
Balance sheet
Equity	2,8 M €	+0.4%	2,8 M €	+0.1%	2,8 M €	+0.5%	2,7 M €	+14.1%	2,4 M €
Total assets	3 M €	-1.2%	3 M €	+0.0%	3 M €	+3.1%	2,9 M €	+9.5%	2,7 M €
Cash	76,7 k €	+102%	38 k €	-30.6%	54,7 k €	-50.6%	110,9 k €	-16.0%	132 k €
Debts	205,6 k €	-18.5%	252,4 k €	-0.8%	254,3 k €	+43.0%	177,8 k €	-32.4%	263,1 k €
Other
Workforce	11,3 ETP	+17.7%	9,6 ETP	+4.3%	9,2 ETP	-5.2%	9,7 ETP	+4.3%	9,3 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

4 active · 4 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Hugues GENETTE	Mandate
Jean-Charles GENETTE	MandateDirector2013 accountsended
Olivier GENETTE	MandateDirector2017 accountsended
Philippe GENETTE	MandateChairman of the board of directors2006 accountsendedManaging director2017 accountsended

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
AVIXIA0401.427.867Represented by Philippe GENETTE	Mandate2020 accountsDirector2017 accounts
Hughes GENETTE	Director2017 accounts
Jean -Charles GENETTE	Director2017 accounts

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	30/09/2026	30/09/2025	13/10/2024	21/11/2023	17/10/2022	29/09/2021
General meeting	29/09/2026	29/09/2025	03/10/2024	12/11/2023	14/10/2022	27/09/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 20 filings

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	29/09/2026	30/09/2026	French	PDF
Abridged model	31/12/2024	29/09/2025	30/09/2025	French	PDF
Abridged model	31/12/2023	03/10/2024	13/10/2024	French	PDF
Abridged model	31/12/2022	12/11/2023	21/11/2023	French	PDF
Abridged model	31/12/2021	14/10/2022	17/10/2022	French	PDF
Abridged model	31/12/2020	27/09/2021	29/09/2021	French	PDF
Abridged model	31/12/2019	12/12/2020	18/12/2020	French	PDF
Abridged model	31/12/2018	27/11/2019	03/12/2019	French	PDF
Abridged model	31/12/2017	24/08/2018	30/08/2018	French	PDF
Abridged model	31/12/2016	17/11/2017	22/11/2017	French	PDF
Abridged model	31/12/2015	25/08/2016	31/08/2016	French	PDF
Abridged model	31/12/2014	13/08/2015	31/08/2015	French	PDF
Abridged model	31/12/2013	20/08/2014	29/08/2014	French	PDF
Abridged model	31/12/2012	20/11/2013	18/12/2013	French	PDF
Abridged model	31/12/2011	30/09/2012	30/11/2012	French	PDF
Abridged model	31/12/2010	01/06/2011	31/08/2011	French	PDF
Abridged model	31/12/2009	17/06/2010	30/08/2010	French	PDF
Abridged model	31/12/2008	18/06/2009	31/08/2009	French	PDF
Abridged model	31/12/2007	19/06/2008	08/01/2009	French	PDF
Abridged model	31/12/2006	30/06/2007	26/09/2007	French	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

4 active · 4 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Hugues GENETTE	Mandate
Jean-Charles GENETTE	MandateDirector2013 accountsended
Olivier GENETTE	MandateDirector2017 accountsended
Philippe GENETTE	MandateChairman of the board of directors2006 accountsendedManaging director2017 accountsended

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
AVIXIA0401.427.867Represented by Philippe GENETTE	Mandate2020 accountsDirector2017 accounts
Hughes GENETTE	Director2017 accounts
Jean -Charles GENETTE	Director2017 accounts

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates16/05/2024
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - DIVERS - DEMISSIONS, NOMINATIONS
PDF
Mandates31/12/2019
DEMISSIONS, NOMINATIONS
PDF
Mandates28/01/2015
DEMISSIONS, NOMINATIONS
PDF
Mandates31/12/2009
Reconduction mandats administrateurs
PDF
Other30/06/2006
Assemblée générale extraordinaire - Modification des statuts - changement
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings20 filings

Mandates

Olivier GENETTE

Jean-Charles GENETTE

Philippe GENETTE

Hugues GENETTE

AVIXIA

Superphar

Jean -Charles GENETTE

Hughes GENETTE

20012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202420252026

PHARMA MANUFACTURING

Rue Guillaume Fouquet,Isnes 16, 5032 Mazy

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Rue Guillaume Fouquet,Isnes 16, 5032 MazyCurrent	accounts 2021 → 2025	Accounts 2025 · 2026-00533611

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
PHARMA MANUFACTURINGCurrent	accounts 2021 → 2025	Accounts 2025 · 2026-00533611

Events

2025
Annual accounts 20256,2 k €↑
2024
Annual accounts 20242,4 k €↓
2023
Annual accounts 202314,3 k €↓
2022
Annual accounts 2022338,1 k €↑
2021
Annual accounts 2021-162,9 k €↓
2020
Annual accounts 2020227,1 k €↓
2019
Annual accounts 2019248,3 k €↑
2018
Annual accounts 2018153,2 k €↑
2017
Annual accounts 201756,2 k €↓
2016
Annual accounts 2016239,4 k €↓
2015
Annual accounts 2015331 k €↓
2014
Annual accounts 2014353,2 k €↑
2013
Annual accounts 2013333,8 k €↑
2012
Annual accounts 2012215,7 k €↓
2011
Annual accounts 2011282,9 k €↑
2010
Annual accounts 2010110,2 k €↑
2009
Annual accounts 20094,4 k €↓
2008
Annual accounts 200835,3 k €↑
2007
Annual accounts 200733,5 k €↑
2006
Annual accounts 2006-118,7 k €
16/07/2001
IncorporationPublic limited company

PHARMA MANUFACTURING

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events